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Abstract
Synaptic signaling involves the release of neurotransmitter from presynaptic active zones (AZs). Proteins that
regulate vesicle exocytosis cluster at AZs, composing the cytomatrix at the active zone (CAZ). At the
Drosophila neuromuscular junction (NMJ), the small GTPase Rab3 controls the distribution of CAZ proteins
across release sites, thereby regulating the efficacy of individual AZs. Here we identify Rab3-GEF as a
second protein that acts in conjunction with Rab3 to control AZ protein composition. At rab3-GEF mutant
NMJs, Bruchpilot (Brp) and Ca2 channels are enriched at a subset of AZs, leaving the remaining sites devoid
of key CAZ components in a manner that is indistinguishable from rab3 mutant NMJs. As the Drosophila
homologue of mammalian DENN/MADD and Caenorhabditis elegans AEX-3, Rab3-GEF is a guanine nucle-
otide exchange factor (GEF) for Rab3 that stimulates GDP to GTP exchange. Mechanistic studies reveal that
although Rab3 and Rab3-GEF act within the same mechanism to control AZ development, Rab3-GEF is
involved in multiple roles. We show that Rab3-GEF is required for transport of Rab3. However, the synaptic
phenotype in the rab3-GEF mutant cannot be fully explained by defective transport and loss of GEF activity.
A transgenically expressed GTP-locked variant of Rab3 accumulates at the NMJ at wild-type levels and fully
rescues the rab3 mutant but is unable to rescue the rab3-GEF mutant. Our results suggest that although
Rab3-GEF acts upstream of Rab3 to control Rab3 localization and likely GTP-binding, it also acts down-
stream to regulate CAZ development, potentially as a Rab3 effector at the synapse.
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Significance Statement
The release of neurotransmitter at synapses is regulated by proteins that form the presynaptic release
machine. We show here that Rab3-GEF is required for controlling the protein composition of release sites
in the Drosophila neuromuscular junction (NMJ). Our results indicate that loss of Rab3-GEF results in the
development of NMJs that are structurally and functionally indistinguishable from NMJs that lack the protein
Rab3. Our studies reveal that Rab3 and Rab3-GEF act within the same molecular mechanism and support
a model wherein Rab3-GEF serves as a Rab3 effector to control active zone protein composition. This work
provides further insight into a novel molecular mechanism that controls the strength of synapses.
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Introduction
At synapses, neurotransmitter exocytosis is regulated
by a complex of release machinery proteins. These pro-
teins aggregate at presynaptic active zones (AZs) to form
the cytomatrix at the active zone (CAZ), which controls the
recruitment, docking, and priming of synaptic vesicles
and enhances calcium channel accumulation (Gundelfin-
ger and Fejtova, 2012). CAZ size and composition is
variable, correlating with site-specific release efficacy. It is
also plastic and can be remodeled to regulate synapse
function (Sigrist and Schmitz, 2011; Michel et al., 2015).
However, the mechanisms that control CAZ assembly and
plasticity remain unclear.
The Drosophila larval neuromuscular junction (NMJ) is
composed of hundreds of release sites defined by the
apposition of postsynaptic clusters of glutamate recep-
tors (GluRs) with presynaptic accumulations of the CAZ
protein Bruchpilot (Brp), the fly ortholog of mammalian
and Caenorhabditis elegans CAST/ERC/ELKS (Atwood
et al., 1993; Marrus and DiAntonio, 2004; Kittel et al.,
2006; Wagh et al., 2006). Several recent studies have
striven to define the molecular mechanisms that control
Brp aggregation at release sites. The number of AZs that
contain Brp is reduced following the disruption of many
proteins, including the cell adhesion proteins teneurin and
neuroligin (Mosca et al., 2012), postsynaptic actin 57B
(Blunk et al., 2014), the serine threonine kinase Unc-51
(Wairkar et al., 2009), the protein phosphatase PP2A
(Viquez et al., 2009), and the vesicle proteins
synaptotagmin-1 (Paul et al., 2015) and Rab3 (Graf et al.,
2009). Of the mutants thus far identified, loss of Rab3
leads to the most severe disruption of Brp localization and
distribution across AZs. At rab3 mutant NMJs, two-thirds
of AZs are devoid of essential CAZ proteins. Rather,
multiple presynaptic components including Brp, calcium
channels, and T-bars are concentrated at a minority of
sites where they form enlarged aggregates each contain-
ing an increased number of CAZ proteins (Graf et al.,
2009; Ehmann et al., 2014). This altered distribution of
CAZ proteins leads to the formation of a small number of
functional sites, each with enhanced release efficacy
(Peled and Isacoff, 2011; Graf et al., 2009).
Rab3 is a member of a large family of small GTPases
that participates in the tethering of vesicles to target
membranes (Bhuin and Roy, 2014). Similar to other small
GTPases, Rab3 activity is controlled by the opposing
actions of GTPase accelerating proteins (GAPs) and gua-
nine nucleotide exchange factors (GEFs) that determine
its GDP- versus GTP-bound state (Cherfils and Zeghouf,
2013). Rab3 function for controlling Brp distribution re-
quires both GTP binding and membrane association
(Chen et al., 2015), but not the binding of the effector
protein RIM (Rab3 interacting molecule; Graf et al., 2012).
However, the mechanism by which Rab3 controls CAZ
formation and the proteins with which Rab3 must interact
are largely unknown.
Through a genetic screen, we now identify Drosophila
Rab3-GEF as an essential regulator of CAZ development
at the NMJ. Rab3-GEF is the orthologue of mammalian
DENN/MADD/Rab3-GEP and C. elegans AEX-3 (Iwasaki
et al., 1997; Wada et al., 1997). We find that loss of
rab3-GEF results in the development of NMJs that are
morphologically and functionally indistinguishable from
rab3 mutant NMJs. Prior work in other organisms indi-
cates that Rab3-GEF acts upstream of Rab3 to control
Rab3 activity via GDP to GTP exchange and by linking
Rab3 to kinesin for proper axonal trafficking (Wada et al.,
1997; Niwa et al., 2008). Consistent with these studies, we
show that Rab3 trafficking is defective in the rab3-GEF
mutant. However, these functions are not sufficient to
explain the rab3-GEF phenotype. Transgenic expression
of Rab3Q80L, a GTP-locked variant of Rab3 that rescues
the rab3 mutant, enhances the accumulation of Rab3 at
rab3-GEF mutant NMJs but still fails to rescue the defec-
tive distribution of AZ components. Thus, in addition to its
roles regulating Rab3 activity and localization, these find-
ings support the model that Rab3-GEF also functions
downstream of Rab3, potentially as a Rab3 effector pro-
tein to dock associated vesicles at active zones.
Materials and Methods
Fly stocks
Flies were maintained at 25°C on standard fly food.
Wild-type (WT) flies were Canton S (CS) or CS outcrossed
to dvglutNMJX-Gal4 (Daniels et al., 2008). The following fly
lines were obtained from the Bloomington Stock Center:
the P-element line P{EPgy2}Rab3-GEFEY06511, the defi-
ciency lines Df(1)ED7289 and Df(2R)ED2076, the UAS-
cacophony-GFP line P(UAS-cac1-EGFP)422A (Kawasaki
et al., 2004), and the UAS-YFP-rab3 line P{UASp-
YFP.Rab3}4EHP05b (Zhang et al., 2007). The rab3rup mu-
tant (Graf et al., 2009) and the lines containing the UAS-
rab3 and UAS-rab3Q80L transgenes (Chen et al., 2015)
were described previously.
Cloning of rab3-GEF cDNA
To generate the 6.3 kb full-length rab3-GEF cDNA, we
cloned two overlapping cDNA fragments spanning the
entire rab3-GEF ORF and then sequentially ligated indi-
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vidual fragments together. In brief, total RNA was ex-
tracted from adult Drosophila heads and reverse-
transcription (RT) reactions were performed using gene-
specific primers to obtain two cDNA fragments: NotI-NheI
and NheI-XbaI. NotI and XbaI sites were introduced into
the 5= end and 3= end, respectively, to facilitate subclon-
ing into the pUAST vector to generate UAS-rab3-GEF.
Generation of rab3-GEF mutants
To generate the collection of EMS mutagenized lines,
isogenic males were fed a solution of 5% sucrose and 10
mM methanesulfonic acid ethyl ester (EMS; Sigma-
Aldrich) for 12–16 h. These males were mated with FM7a
balanced females. 2000 F1 female virgin offspring were
individually crossed with FM7a balanced males to create
the stock collection used in the anatomical genetic
screen.
Deletion of the rab3-GEF gene was generated by im-
precise excision of the P-element P{EPgy2}Rab3-
GEFEY06511, which is located within an intron near the 3=
end of the rab3-GEF gene. To initiate the excision, ho-
mozygous y, w-, P{EPgy2}Rab3-GEFEY06511 females were
crossed to y, w-/Y; Xa/CyO; 2-3, Sb males carrying the
transposase. F1 male progeny y, w
-, P{EPgy2}Rab3-
GEFEY06511/Y; /CyO; /2-3, Sb were collected and
crossed to FM7j, B1 females. The F2 progeny were
screened for white-eyed females, which were crossed
individually to FM7j, B1/Ymales to set up stocks that were
subsequently screened by PCR to identify those in which
DNA surrounding the P-element had been excised. A
single mutant with a substantial excision was identified,
rab3-GEFSC225, and the following primer pairs were cho-
sen to span the excised region, creating a PCR product
that was sequenced to determine the precise nature of
the excision: 5=-GCGTCACTTCTCCGATTCCG-3= and 5=-
CCCTTCTGGGTGAAGCACTTGCGG-3=.
Antibody generation
Polyclonal anti sera were generated against a synthetic
Rab3-GEF peptide (CDSDRELTSRRDSDQQRLH). The
peptide was conjugated to KLH and injected into rabbits
for the generation of antiserum (YenZym Antibodies). The
antiserum was affinity purified using the peptide conju-
gated to SulfoLink Coupling Resin (Thermo Scientific).
The antibodies were eluted from the affinity column using
0.1 M glycine, pH 2.7. The purified -Rab3-GEF antibody
was used at 1:500.
Immunohistochemistry
Third-instar larvae were dissected in PBS and fixed in
either Bouin’s fixative for 5 min or 4% formaldehyde for 20
min. Larvae were washed with PBS containing 0.1% Tri-
ton X-100 (PBT) and blocked in 5% NGS in PBT for 30
min, followed by overnight incubation in primary antibod-
ies in 5% NGS in PBT, three washes in PBT, incubation in
secondary antibodies in 5% NGS in PBT for 45 min, three
final washes in PBT, and equilibration in 70% glycerol in
PBS. Samples were mounted in VectaShield (Vector Lab-
oratories). The following primary antibodies were used:
mouse -Brp, 1:250 (Developmental Studies Hybridoma
Bank), rabbit -DGluRIII, 1:2500 (Marrus et al., 2004), and
rabbit -Rab3, 1:1000. Goat Cy3-conjugated secondary
antibodies against mouse and rabbit IgG and Cy3- and
AlexaFluor 647-conjugated goat -HRP were used at
1:1000 and were obtained from Jackson ImmunoRe-
search. AlexaFluor 488-conjugated goat secondary anti-
body against rabbit IgG and AlexaFluor 647-conjugated
secondary antibodies against mouse and rabbit IgG were
used at 1:1000 and were obtained from Life Technologies.
FITC-conjugated goat -GFP was used at 1:500 and was
obtained from Abcam. Antibodies obtained from the De-
velopmental Studies Hybridoma Bank were developed
under the auspices of the National Institute of Child Health
and Human Development and maintained by the Depart-
ment of Biological Sciences of the University of Iowa,
Iowa City, IA.
Imaging and analysis
Samples were imaged using a Nikon C2 confocal mi-
croscope. All genotypes for an individual experiment were
imaged at the same gain and set such that signals from
the brightest genotype for a given experiment were not
saturating. NM4b NMJs on muscle 4 were analyzed. Im-
ages were analyzed using MetaMorph software (Molecu-
lar Devices). Statistical analysis was performed using
either Student’s t test or ANOVA followed by Bonferroni’s
test for comparison of samples within an experimental
group. All histograms and measurements are shown as
meanSEM. Statistical analyses are summarized in
Table 1. Italicized superscript letters associated with p
values correspond to rows in the table.
To determine the percentage of GluR clusters apposed
by Brp, Brp, and DGluRIII puncta were manually counted,
and DGluRIII clusters that were not opposite to a detect-
able Brp punctum were counted as unapposed DGluRIII
clusters. MetaMorph software was used for the quantifi-
cation of Brp puncta size, Cacophony-GFP cluster size,
and Rab3 average intensity. For measurement of Brp
area, thresholds were kept constant across all genotypes
for a given experiment. Although most Brp puncta were
distinct, occasional overlapping puncta were separated
with the cut drawing tool. For measurements of Rab3
intensity at the NMJ, the area of the NMJ was first defined
by HRP and Brp signal. For measurements of Rab3 inten-
sity in the nerve, the area of a nerve segment was first
defined by HRP signal. The average intensity of Rab3
signal within each defined NMJ or nerve segment was
then calculated, and the average background intensity
was subtracted.
Electrophysiology
Two electrode voltage-clamp recordings were done in
muscle six of abdominal segments A3 and A4 of wander-
ing third instar larvae. Electrodes with resistances be-
tween 10 and 20 M were used. The cells were held at
70 mV in a modified HL-3 saline solution (Stewart et al.,
1994) containing the following (in mM): 70 NaCl, 5 KCl, 10
NaHCO3, 115 sucrose, 5 trehalose, 5 HEPES, 0.4 CaCl,
and 10 MgCl. Recordings were done in voltage-clamp
mode using an AxoClamp 2B Amplifier (Axon Instruments)
low-pass filtered at 1kHz, and digitized at 10 kHz with an
Instrutech ITC-18 computer interface using Patchmaster
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Software (HEKA Electronics). Cells requiring 1 nA or more
holding current were discarded. Spontaneous events
were recorded for 1 min and the average amplitude and
frequency of the spontaneous events was quantified us-
ing Mini Analysis Software (Synaptosoft). For stimulated
excitatory junctional currents (EJCs), AgCl2 wire in a glass
suction electrode was used to stimulate the cut end of the
segmental nerve for 1 ms at 1.5 the threshold voltage. A
Master 8 stimulator and Isoflex stimulation isolation unit
(AMPI) were used to control the duration and amplitude of
the stimulation. The elicited currents from 10 successive
stimulation protocols were averaged off-line using custom
programs written by Josef Trapani (Amherst College) in
Igor Pro software (WaveMetrics). For stimulus trains, the
nerve was stimulated with 10 trains of five pulses at 20 Hz
with 5 s rest intervals between trains. The 10 trains were
averaged and the amplitudes of the first and fifth pulse
were used to calculate the facilitation index. Histograms
and measurements are shown as meanSEM. Statistical
analyses are summarized in Table 1. Italicized superscript
letters associated with p values correspond to rows in the
table.
Results
rab3-GEF mutants display defective Brp distribution
To identify proteins that control CAZ assembly and
active zone composition, we conducted an anatomical
genetic screen on a collection of EMS mutagenized Dro-
sophila lines. A set of 	2000 homozygous mutant larvae
carrying mutagenized X chromosomes were dissected
and costained with antibodies against the presynaptic
active zone protein Brp and the essential glutamate re-
ceptor subunit DGluRIII. Immunostained NMJs were visu-
alized by fluorescence microscopy and assessed for
defects in Brp localization and distribution across active
zones, including changes in Brp puncta size and number
and the apposition of Brp with postsynaptic glutamate
receptor clusters. From this screen, we identified two
lines, MA18 and MA20, which displayed a prominent Brp
distribution phenotype (Fig. 1). At MA18 and MA20 mu-
tant NMJs, gross NMJ morphology and -DGluRIII stain-
ing appears normal. However, Brp aggregates at only a
subset of active zones in puncta that are significantly
larger than normal, leaving the majority of GluR clusters
unapposed to a Brp-positive AZ (Fig. 1B).
We noted that the distribution of Brp in MA18 and
MA20 mutant NMJs was remarkably similar to the synap-
tic phenotype observed in rab3 mutant larvae (Graf et al.,
2009). However, ma18 and ma20 are not mutant alleles of
rab3 as they map to the X chromosome whereas rab3 is
on the second chromosome. To determine the gene re-
sponsible for the synaptic phenotype observed in MA18
and MA20 mutant NMJs, we first mapped the mutations
by complementation testing. MA18 and MA20 are reces-
sive alleles and transheterozygous larvae carrying both
MA18 and MA20 failed to complement one another, sug-
gesting that they are mutant alleles of the same gene. We
identified the deficiency chromosome Df(1)ED7289 as fail-
ing to complement both MA18 and MA20 (Fig. 1B). This
deficiency deletes 18 predicted genes between 13A5 and
Table 1. Statistical Table
Data structure Type of test Power (
0.05)
a (Fig. 2B) Normally distributed ANOVA followed by Bonferroni’s test 1
b (Fig. 2C) Normally distributed ANOVA followed by Bonferroni’s test 1
c (Fig. 2E) Normally distributed Student’s t test 1
d Normally distributed ANOVA followed by Bonferroni’s test 1
e Normally distributed ANOVA followed by Bonferroni’s test 1
f Normally distributed Student’s t test 0.05241
g Normally distributed ANOVA followed by Bonferroni’s test 1
h Normally distributed ANOVA followed by Bonferroni’s test 1
i (Fig. 4B) Normally distributed ANOVA followed by Bonferroni’s test 1
j (Fig. 4C) Normally distributed ANOVA followed by Bonferroni’s test 1
k Normally distributed ANOVA followed by Bonferroni’s test 0.07662
l Normally distributed ANOVA followed by Bonferroni’s test 0.15701
m (Fig. 5B) Normally distributed ANOVA followed by Bonferroni’s test 1
n Normally distributed ANOVA followed by Bonferroni’s test 0.15085
o Normally distributed ANOVA followed by Bonferroni’s test 0.13093
p (Fig. 7C) Normally distributed Student’s t test 1
q (Fig. 7D) Normally distributed Student’s t test 1
r (Fig. 7D) Normally distributed Student’s t test 1
s (Fig. 7E) Normally distributed Student’s t test 1
t (Fig. 8B) Normally distributed ANOVA followed by Bonferroni’s test 1
u (Fig. 8D) Normally distributed ANOVA followed by Bonferroni’s test 1
v (Fig. 8E) Normally distributed ANOVA followed by Bonferroni’s test 1
w Normally distributed Student’s t test 0.05575
x Normally distributed Student’s t test 0.0937
y Normally distributed Student’s t test 1
z Normally distributed Student’s t test 0.99976
aa Normally distributed Student’s t test 0.0588
bb Normally distributed Student’s t test 0.13625
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13A12, including rab3-GEF, the Drosophila orthologue of
mammalian DENN/MADD/Rab3-GEP and C. elegans
AEX-3. In mammals and C. elegans, DENN/MADD/Rab3-
GEP and AEX-3 are important regulators of Rab3, acting
as GEFs that catalyze GDP to GTP exchange, and dis-
ruption of these genes results in defective Rab3 function
(Iwasaki et al., 1997; Wada et al., 1997; Oishi et al., 1998;
Coppola et al., 2002; Mahoney et al., 2006; Niwa et al.,
2008). Due to the similarity between rab3 mutant and
MA18 and MA20 mutant NMJs, we tested whether rab3-
GEF was responsible for the synaptic phenotype in MA18
and MA20 mutant larvae.
We first analyzed the structure and sequence of the
Drosophila rab3-GEF gene. Sequence of the rab3-GEF
transcript had been predicted by analysis of incomplete
CDS clones but no full-length rab3-GEF cDNA had been
identified. To determine experimentally the sequence of
the rab3-GEF coding region, we cloned the gene in two
overlapping cDNA fragments from mRNA extracted from
adult Drosophila heads and ligated the two fragments
together to form a 6.3 kb cDNA that spanned the entire
rab3-GEF open reading frame. Examination of the full-
length cDNA indicates that the Drosophila rab3-GEF tran-
script codes for a 2115 aa protein that contains the
standard domains present in its mammalian and C. el-
egans orthologues (Schievella et al., 1997; Chow et al.,
1998; Levivier et al., 2001; Marat et al., 2011), including an
N-terminal tripartite DENN domain composed of the typ-
ical uDENN (upstream DENN), DENN, and dDENN (down-
stream DENN) modules and a single Death domain (DD)
near its C-terminal end (Fig. 1A). Drosophila Rab3-GEF is
500–700 amino acids longer than its orthologues due to
a modest lengthening of the regions separating domains
and the addition of 300 amino acids at its C-terminal
end following the Death domain.
Sequencing of rab3-GEF in theMA18 andMA20mutant
lines revealed mutations within rab3-GEF coding regions
predicted to disrupt or eliminate important domains (Fig.
Figure 1. Bruchpilot distribution is disrupted in rab3-GEF mutant NMJs. A, Schematic representations of the cloned WT Drosophila
rab3-GEF gene, the rab3-GEFMA18 and rab3-GEFMA20 mutant genes generated by EMS mutagenesis, and the rab3-GEFSC225 mutant
gene generated by P-element excision. Magenta exonic regions correspond to the tripartite DENN domain composed of the uDENN,
DENN, and dDENN modules. The green exonic region corresponds to the DD. Arrowheads identify the Q1862STOP and G460E point
mutations associated with the rab3-GEFMA18 and rab3-GEFMA20 mutant alleles, respectively. Boxed region of the rab3-GEFSC225
mutant allele denotes the part of the gene that is excised. B, Confocal images of muscle 4 NMJs costained with antibodies against
the presynaptic AZ protein Brp (magenta) and the postsynaptic receptor DGluRIII (green) from WT (CS), rab3-GEFMA18 mutant
(rab3-GEFMA18/Df(1)ED7289) and rab3-GEFMA20 mutant (rab3-GEFMA20/Df(1)ED7289) third-instar larvae. Scale bar, 2 m.
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1A). rab3-GEFMA18 contains a nonsense mutation that
results in a premature stop codon in place of a glutamine
residue at position 1682 downstream of the Death Do-
main. rab3-GEFMA20 contains a missense mutation in
which glycine 460 is replaced by glutamate (G460E). Res-
idue 460 is located within the second DENNmodule of the
tripartite DENN domain among a sequence of primarily
non-polar amino acids. Although the precise functional def-
icits of Rab3-GEF in the MA18 and MA20 lines remain un-
known, our analysis indicates that rab3-GEFMA18 and rab3-
GEFMA20 are mutant alleles of rab3-GEF, and their lack of
complementation with each other and Df(1)ED7289 suggests
that the observed active zone phenotype in each is due to
rab3-GEF dysfunction.
rab3-GEFSC225 phenocopies the active zone
phenotype of the rab3 mutant
Because the mutations present in the rab3-GEFMA18 and
rab3-GEFMA20 alleles do not result in clear functional nulls,
we generated a third rab3-GEF mutant by excision of a
transposable P-element located within an intron near the
3= end of the gene. Imprecise excision of P{EPgy2}Rab3-
GEFEY06511 generated rab3-GEFSC225 which contains a
large excision that results in the deletion of the majority of
the rab3-GEF gene, including the start codon and part of
the predicted 5= UTR (Fig. 1A). In the rab3-GEFSC225
mutant, the entire coding region is removed except for the
last three exons that code for the final 364 amino acids of
the protein, which is unlikely to be expressed because
there is no start codon. Thus, we hypothesized that rab3-
GEFSC225 should represent a genetic and functional null
allele of rab3-GEF and utilized it as a basis for our sub-
sequent studies of Rab3-GEF function.
Initial analysis of the MA18 and MA20 mutants indi-
cated that rab3-GEF disruption results in defective Brp
distribution across active zones. Examination of Brp and
DGluRIII localization in the rab3-GEFSC225 mutant demon-
strates that excision of the rab3-GEF gene also results in
the concentration of Brp protein at a small fraction of
available sites (Fig. 2A). Quantification of immunostained
NMJs reveals that whereas Brp is apposed to nearly all
GluR clusters at WT NMJs, in the rab3-GEFSC225 mutant,
only one-third of GluR clusters are apposed to a Brp
punctum (Fig. 2B). Furthermore, average Brp punctum
size is twice as large in the rab3-GEFSC225 mutant com-
pared with WT (Fig. 2C). In addition, Brp-GluR apposition
and average Brp area are the same in both homozygous
rab3-GEFSC225 mutant larvae and transheterozygotes of
rab3-GEFSC225 and Df(1)ED7289 (Fig. 2A–C), indicating
that rab3-GEFSC225 behaves as a genetic null. Despite the
observed active zone phenotype, rab3-GEFSC225 mutants
are both viable and fertile.
In mammals and C. elegans, loss of DENN/MADD/
Rab3-GEP and AEX-3 causes defects in Rab3 function
(Iwasaki et al., 1997; Yamaguchi et al., 2002; Mahoney
et al., 2006; Niwa et al., 2008). To determine whether loss
of Rab3-GEF mimics loss of Rab3, we compared Brp
distribution between the two mutants and examined the
degree of similarity (Fig. 2A–C). Quantification reveals no
difference in Brp localization between rab3/Df and rab3-
GEFSC225/Df mutants, both in terms of percentage of GluR
clusters apposed to Brp (p
0.601a) and average Brp area
(p
0.156b). Interestingly, rab3-GEFSC225 is the first mu-
tant identified to have a Brp distribution phenotype that is
indistinguishable from the rab3 mutant.
We also wished to quantify the severity of the Brp
distribution phenotype in rab3-GEFMA18 and rab3-
GEFMA20 mutant NMJs where the functional disruption of
Rab3-GEF is less clear. Whereas the percentage of GluR
clusters apposed to Brp in rab3-GEFMA18 and rab3-
GEFMA20 mutant NMJs is significantly reduced compared
with WT, the reduction is slightly less severe than in the
rab3 mutant (CS: 93.8  0.9%; rab3-GEFMA18/
Df(1)ED7289: 38.0  1.3%; rab3-GEFMA20/Df(1)ED7289:
39.4 1.6%; rab3rup/Df(2R)ED2076: 31.6 1.2%; n
 10
NMJs for all genotypes; p0.000001d for CS vs MA18
and MA20; p
0.00499d for rab3 vs MA18; p
0.000393d
for rab3 vs MA20). Conversely, average Brp area is similar in
rab3-GEFMA18 and rab3-GEFMA20, and rab3mutant NMJs (CS:
0.19  0.005 m2; rab3-GEFMA18/Df(1)ED7289: 0.41  0.014
m2; rab3-GEFMA20/Df(1)ED7289: 0.44  0.010 m2; rab3rup/
Df(2R)ED2076: 0.43  0.011 m2; n 
 10 NMJs for all geno-
types; p0.000001e for CS vsMA18 andMA20; p
1.00e for
rab3 vs MA18 and MA20). These results suggest that rab3-
GEFMA18 and rab3-GEFMA20 behave as strong hypomorphs.
Our results indicate that Brp distribution is indistin-
guishable between rab3-GEFSC225 and rab3 mutant
NMJs. Do other morphological similarities exist? In rab3
mutant NMJs, multiple presynaptic components required
for vesicle release are concentrated at the active zones
where Brp is aggregated, including calcium channels
(Graf et al., 2009). To determine whether presynaptic
calcium channels are distributed similarly at rab3-
GEFSC225 mutant NMJs, we used the Gal4/UAS system to
express a GFP-tagged version of the calcium channel
subunit Cacophony in motor neurons (Fig. 2D). When
expressed in WT neurons, cacophony-GFP accumulates
opposite DGluRIII at the majority of release sites. Con-
versely, in rab3-GEFSC225 mutant NMJs, Cacophony-GFP
aggregates selectively at Brp-positive active zones, failing
to accumulate opposite the majority of DGluRIII clusters
(Fig. 2D). Furthermore, aggregations of cacophony-GFP
protein are larger in the rab3-GEFSC225 mutant compared
with WT (Fig. 2E). Thus, in terms of both Brp and calcium-
channel distribution, the rab3-GEFSC225 mutant pheno-
copies the morphological defects observed at rab3
mutant NMJs. These results are consistent with the hy-
pothesis that Rab3 function is compromised in the rab3-
GEFSC225 mutant and that the developmental defects
observed in the two mutants are mechanistically related.
Rab3-GEF localizes to both the NMJ and cell body
Our morphological analysis indicates that rab3-GEF dys-
function results in defective AZ development. To study
how Rab3-GEF functions to control synapse develop-
ment, we first examined where Rab3-GEF protein local-
izes within Drosophila neurons. We generated a
polyclonal antibody to a protein epitope in the region
separating the uDENN and DENN modules of Drosophila
Rab3-GEF. This antibody stains WT NMJs in a mottled
New Research 6 of 19
March/April 2016, 3(2) e0031-16.2016 eNeuro.sfn.org
Figure 2. The altered distribution of Brp in rab3-GEFSC225 mutant NMJs is identical to the rab3 mutant and results in the clustering
of Ca2 channels at a small number of release sites. A, Images of NMJs costained with -Brp (magenta) and -DGluRIII (green) from
CS, homozygous rab3-GEFSC225 mutant larvae, rab3-GEFSC225/Df(1)ED7289 mutant larvae, and rab3rup/Df(2R)ED2076 mutant larvae.
Scale bar, 2 m. B, C, Histograms show (B) the average percentage of DGluRIII clusters apposed to Brp puncta per NMJ and (C) the
average area of individual Brp puncta for the genotypes listed in A. n 
 10 NMJs for all genotypes; (B) p0.000001a versus CS;
(C) p0.000001b versus CS. D, Images of NMJs expressing cacophony-GFP (green) driven by dvglutNMJX-Gal4 in from WT
(dvglutNMJX-Gal4/; UAS-Cacophony-GFP/) and rab3-GEFSC225 mutant (dvglutNMJX-Gal4, rab3-GEFSC225/Df(1)ED7289; UAS-
New Research 7 of 19
March/April 2016, 3(2) e0031-16.2016 eNeuro.sfn.org
pattern throughout the synaptic terminal (Fig. 3A).
-Rab3-GEF and -Brp staining partially overlap, al-
though regions of greater Rab3-GEF intensity have a
tendency to be adjacent to Brp puncta rather than colo-
calizing with them (Fig. 3A, inset). Because Rab3-GEF
may regulate Rab3 function, we also examined the degree
of colocalization between Rab3 and Rab3-GEF at the
NMJ by expressing YFP-tagged Rab3 in WT neurons with
the dvglutNMJX-Gal4 driver (Fig. 3B). Rab3-GEF and YFP-
Rab3 also partially overlap, although the colocalization
between YFP-Rab3 and Brp is more prominent, as de-
scribed previously for endogenous Rab3 (Graf et al.,
2009; Chen et al., 2015). In addition, Rab3-GEF localiza-
tion at the NMJ appears generally unaffected by rab3
disruption. The average intensity of Rab3-GEF staining at
rab3 mutant NMJs is similar to WT (CS: 100.0  4.4 a.u.;
rab3/Df: 99.1  4.0 a.u.; n 
 8 NMJs for both genotypes;
p
0.879f).
Examination of the larval ventral nerve cord (VNC) also
reveals prominent -Rab3-GEF staining in the cell bodies
and neuropil of the brain (Fig. 3C), suggesting that Dro-
sophila Rab3-GEF may function both in neuronal cell
bodies and at the synapse. Importantly, -Rab3-GEF sig-
nal is completely absent in rab3-GEFSC225 mutant ani-
mals, both at the NMJ and in the brain (Fig. 3A,C),
indicating that the antibody is specific for Rab3-GEF and
that Rab3-GEF protein is not expressed in the rab3-
GEFSC225 mutant.
We also examined Rab3-GEF protein localization in the
hypomorphic rab3-GEFMA18 and rab3-GEFMA20 mutants.
Rab3-GEF immunostaining reveals that the MA18 point
mutation results in a decrease in Rab3-GEF protein. Av-
erage Rab3-GEF intensity is significantly reduced at the
NMJ (CS: 100.0  6.8 a.u.; rab3-GEFMA18/Df: 5.9  0.5
a.u; n 
 8 NMJs for both genotypes; p0.000001g) and
within the cell body enriched cortex of the VNC (CS: 100.0
 5.3 a.u.; rab3-GEFMA18/Df: 28.6  2.3 a.u.; n 
 8 single
optical sections for both genotypes; p0.000001h). Con-
versely, in the rab3-GEFMA20 mutant, Rab3-GEF staining
is close to normal in VNC cell bodies (CS: 100.0  5.3
a.u.; rab3-GEFMA20/Df: 84.5  4.5 a.u.; n 
 8 single
optical sections for both genotypes; p
0.04962h) but is
nearly absent at NMJs (CS: 100.0  6.8 a.u.; rab3-
GEFMA20/Df: 5.0  0.5 a.u; n 
 8 NMJs for both geno-
types; p0.000001g). Because the rab3-GEFMA20mutant
has a strong phenotype, the selective loss of Rab3-GEF at
mutant NMJs but not within cell bodies suggests that
there may be a local requirement for Rab3-GEF protein at
the NMJ.
Transgenic expression of UAS-Rab3-GEF rescues
Brp distribution
The complete loss of Rab3-GEF protein in the rab3-
GEFSC225 mutant suggests that the AZ phenotype is due
to the absence of rab3-GEF. However, to ensure that the
loss of Rab3-GEF is responsible for the synaptic devel-
opment defects observed in the rab3-GEFSC225 mutant
and to assess cell autonomy, we expressed transgenic
rab3-GEF in the rab3-GEFSC225 mutant background using
the Gal4/UAS system. Neuronal expression of UAS-rab3-
GEF by the dvglutNMJX-Gal4 driver fully rescues the Brp
distribution phenotype of the rab3-GEFSC225 mutant (Fig.
4A). Whereas Brp fails to cluster at	60% of GluR clusters
in the rab3-GEFSC225 mutant, the percentage of GluR
clusters apposed to Brp is similar to WT when UAS-rab3-
GEF is expressed in the rab3-GEFSC225 mutant (Fig. 4B).
Transgenic expression of UAS-rab3-GEF also reduces
average Brp puncta size to WT levels (Fig. 4C). Hence,
neuronal expression of Rab3-GEF is required for proper
AZ development.
Rab3-GEF is required for normal short-term
facilitation
Loss of Rab3-GEF results in the defective distribution of
AZ components across release sites in a manner that is
similar to rab3 mutant NMJs. Because release efficacy is
related to Brp accumulation (Marrus and DiAntonio, 2004;
Peled and Isacoff, 2011; Peled et al., 2014), our morpho-
logical analysis suggests that rab3-GEFSC225 mutant
NMJs are composed primarily of very low probability,
Brp-negative sites interspersed by high probability sites
where Brp and calcium channels are concentrated. At
rab3 mutant NMJs, a similar distribution of AZ compo-
nents results in defective release during high-frequency
stimulation but normal release at low-stimulation frequen-
cies (Graf et al., 2009). To determine the effect of rab3-
GEF excision on NMJ function and examine how synaptic
function compares between rab3 mutant and rab3-
GEFSC225 mutant larvae, we performed voltage-clamp re-
cordings from muscle 6 of segments A3 and A4 at WT,
rab3-GEFSC225mutant, and rab3mutant NMJs. In all three
genotypes, spontaneous miniature EJC amplitude is sim-
ilar (WT: 0.64  0.03 nA, n 
 11; rab3-GEF/Df: 0.61 
0.03 nA, n
 13; rab3/Df: 0.66 0.04 nA, n
 12; p
1.00k
for rab3-GEF vs WT; p
0.829k for rab3-GEF vs rab3).
Furthermore, when evoked by low-frequency stimuli in 0.4
mM Ca2, EJC amplitude is comparable between the
three genotypes (WT: 31.6 3.0 nA, n
 13; rab3-GEF/Df:
38.3  3.7 nA, n 
 13; rab3/Df: 35.2  5.4 nA, n 
 12;
p
0.744l for rab3-GEF vs WT; p
1.00l for rab3-GEF vs
rab3). Thus, similar to the rab3 mutant, at low-stimulation
frequencies synaptic strength is normal at rab3-GEFSC225
mutant NMJs even though the number (n) of AZs contain-
ing key presynaptic components is decreased.
In the rab3 mutant, evoked vesicle release occurs at
Brp-positive sites where the probability of release (p) is
enhanced due to the augmented concentration of CAZ
components (Graf et al., 2009; Peled and Isacoff, 2011).
continued
Cacophony-GFP/) larvae. NMJs are costained with -Brp (magenta) and -DGluRIII (blue) antibodies. Scale bar, 2 m. E, Histogram
shows the average area of cacophony-GFP clusters for the genotypes listed in D. n 
 10 NMJs for both genotypes; p0.000001c
versus WT.
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The increased p at these sites maintains neurotransmitter
release despite the reduction in n, leading to normal EJC
amplitude at low-stimulation frequencies. However, the
enhanced release probability of rab3 mutant active zones
results in defective short-term facilitation (Graf et al.,
2009). At WT NMJs composed primarily of lower proba-
bility release sites, high-frequency stimulation in low
extracellular calcium results in facilitation. EJC size in-
Figure 3. -Rab3-GEF immunostaining reveals Rab3-GEF protein at the NMJ and in ventral nerve cord cell bodies and neuropil. A,
Images of NMJs immunostained with -Rab3-GEF (green) and -Brp (magenta) from CS and rab3-GEFSC225/Df(1)ED7289 mutant
larvae. Inset, Magnified view of boxed region, indicating partial overlap of -Rab3-GEF and -Brp signal but little colocalization. Scale
bars: lower-magnification images, 2 m; higher-magnification inset, 1 m. B, Image of a single bouton of a WT NMJ expressing
UAS-rab3-YFP (magenta) driven by the dvglutNMJX-Gal4 driver and costained with -Rab3-GEF (green) and -Brp (blue). Scale bar,
1 m. C, Single optical sections of ventral nerve cords from CS and rab3-GEFSC225/Df(1)ED7289 mutant larvae immunostained with
-Rab3-GEF (green) and -Brp (magenta). In WT brains, Rab3-GEF immunostaining is prominent in the neuropil, as well as in the
surrounding neuronal cell bodies visualized by cytosolic Rab3-GEF surrounding immuno-negative nuceli. Scale bar, 20 m.
New Research 9 of 19
March/April 2016, 3(2) e0031-16.2016 eNeuro.sfn.org
creases with each subsequent pulse, likely due to a
buildup of residual calcium in the axon terminal (Zucker
and Regehr, 2002). Conversely, facilitation is attenuated
at NMJs with primarily high probability sites, such as is
observed in the rab3 mutant (Graf et al., 2009). Is short-
term facilitation also defective in the rab3-GEFSC225 mu-
tant? To assay short-term facilitation, we stimulated WT,
rab3-GEFSC225 mutant, and rab3 mutant NMJs with a
short train of action potentials evoked at a frequency of 20
Hz in 0.4 mM Ca2. To determine the magnitude of facil-
itation in each genotype, the facilitation index (FI) was
calculated by dividing the amplitude of the fifth EJC by the
first. Whereas facilitation is observed at WT NMJs, it is
nearly absent in the rab3-GEFSC225 mutant (Fig. 5). De-
fective facilitation in the rab3-GEFSC225 mutant is equiva-
lent to that observed in the rab3 mutant, resulting in
similar FIs between the two genotypes (p
0.448m). Con-
versely, facilitation is rescued to WT levels when the
UAS-rab3-GEF transgene is expressed in rab3-GEFSC225
mutant neurons (Fig. 5). Hence, these results suggest that
the functional release sites in rab3-GEFSC225 mutant
NMJs have a high p and fire in low calcium concentra-
tions. Additional low p sites are likely not recruited follow-
ing subsequent stimuli, resulting in reduced facilitation.
Our functional and morphological data are consistent,
together indicating that rab3-GEFSC225 mutant NMJs con-
tain a reduced number of functional sites that each have
a high probability of release. Furthermore, our findings
reveal that loss of rab3-GEF phenocopies both the altered
distribution of CAZ components and defective function of
rab3 mutant NMJs.
Rab3 and Rab3-GEF act within the same pathway to
control AZ development
Because loss of Rab3-GEF mimics the loss of Rab3, we
hypothesize that the two proteins act via the same mo-
lecular pathway to control the distribution of active zone
components. To test whether Rab3 and Rab3-GEF act
through the same mechanism or separate, parallel path-
ways, we examined Brp distribution in rab3/rab3-GEF
double-mutant larvae. If rab3rup and rab3-GEFSC225 mu-
tant alleles disrupt separate pathways, larvae mutant for
both genes should display an enhanced phenotype result-
ing from an additive effect. Alternatively, if they act
through the same pathway, disruption of both genes
should result in NMJs that are identical to single knockout
of each gene. Examination of -Brp and -DGluRIII im-
munostaining in rab3/rab3-GEF double mutant larvae
Figure 4. Neuronal expression of transgenic rab3-GEF rescues Brp distribution in rab3-GEFSC225 mutant NMJs. A, Images of NMJs costained
with -Brp (magenta) and -DGluRIII (green) from WT (dvglutNMJX-Gal4/), the rab3-GEFSC225 mutant (dvglutNMJX-Gal4, rab3-GEFSC225/
Df(1)ED7289), and rescue larvae corresponding to the rab3-GEFSC225 mutant with neuronal expression of UAS-rab3-GEF (dvglutNMJX-Gal4,
rab3-GEFSC225/Df(1)ED7289; UAS-rab3-GEF/). Scale bar, 2 m. B, C, Histograms show (B) the average percentage of DGluRIII clusters
apposed to Brp puncta per NMJ and (C) the average area of individual Brp puncta for the genotypes listed in A. n
 11 NMJs for all genotypes;
(B) p0.000001i versus both WT and rescue larvae; (C) p0.000001j versus both WT and rescue larvae.
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reveals no difference in Brp distribution across AZs com-
pared with rab3 and rab3-GEFSC225 single mutants (Fig.
6). The percentage of GluR clusters apposed to Brp is
similar between the rab3/rab3-GEF double-mutant and
each single mutant (p
0.902n for rab3-GEF vs double-
mutant; p
1.00n for rab3 vs double-mutant; Fig. 6B). In
addition, average Brp puncta area is equivalent between
all three genotypes (p
1.00° for rab3-GEF vs double-
mutant; p
0.986° for rab3 vs double-mutant; Fig. 6C).
These results support the hypothesis that Rab3 and
Rab3-GEF act within the same molecular pathway to
control Brp distribution.
rab3-GEF mutation results in defective Rab3
trafficking
How does Rab3-GEF function to control NMJ develop-
ment? Prior work in mammals and C. elegans indicates
that DENN/MADD/Rab3-GEP and AEX-3 can act up-
stream of Rab3 to control Rab3 function via two separate
mechanisms. Orthologues of Drosophila Rab3-GEF cata-
lyze GTP to GDP exchange to increase the population of
active, GTP-bound Rab3 (Oishi et al., 1998; Coppola
et al., 2002; Mahoney et al., 2006). In addition, DENN/
MADD/Rab3-GEP and AEX-3 are required for the antero-
grade axonal trafficking of Rab3 from the cell body to
distal synapses, acting as a linker between GTP-bound
Rab3 and the kinesin family proteins KIF1A and KIF1B
(Iwasaki et al., 1997; Niwa et al., 2008). However, Rab3-
GEF may also act downstream of Rab3 function. Studies
of synaptic vesicle exocytosis in mammalian neurons in-
dicate that DENN/MADD/Rab3-GEP acts via an unidenti-
fied postdocking mechanism to control vesicle fusion
(Yamaguchi et al., 2002). Furthermore, because Rab3-
GEF has been identified as a Rab3 effector during axonal
trafficking, it may also act as a Rab3 effector at the AZ
itself.
To determine how Rab3-GEF functions in Drosophila
neurons to control active zone protein composition, we
first asked whether Drosophila Rab3-GEF is required for
the trafficking of Rab3 to NMJs by analyzing the localiza-
tion of Rab3 in the rab3-GEFSC225 mutant. As described
previously (Graf et al., 2009), Rab3 localizes throughout
WT NMJs in a pattern suggestive of synaptic vesicleFigure 5. Short-term facilitation is defective in the rab3-
Figure 5. continued
GEFSC225 mutant. A Representative EJC traces of a train of five
stimuli given at a frequency of 20 Hz in 0.40 mM Ca2 from WT
(dvglutNMJX-Gal4/), the rab3-GEFSC225 mutant (dvglutNMJX-
Gal4, rab3-GEFSC225/Df(1)ED7289), rescue larvae corresponding
to the rab3-GEFSC225 mutant with neuronal expression of UAS-
rab3-GEF (dvglutNMJX-Gal4, rab3-GEFSC225/Df(1)ED7289;;UAS-
rab3-GEF/), and rab3 mutant larvae (dvglutNMJX-Gal4/;
rab3rup/Df(2R)ED2076). The stimulation artifact has been re-
moved for clarity. B, Histogram showing quantification of the
average FI for each of the four genotypes listed in A, calculated
by dividing the amplitude of the fifth EJC by the amplitude of the
first EJC in a 20 Hz stimulus train. WT, n 
 13; rab3-GEFSC225
mutant, n
 12; rab3-GEFSC225with rescue, n
 14; rab3mutant,
n 
 9; p0.000001m versus both WT and rescue larvae;
#p
1.83  106 m versus WT.
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proteins but with aggregation at active zones visualized
by colocalization with Brp. However, Rab3 accumulation
at the NMJ is disrupted in the rab3-GEF mutant (Fig. 7A).
The average intensity of -Rab3 signal at the NMJ is
reduced by approximately 65% in the rab3-GEFSC225 mu-
tant compared with WT (Fig. 7C). Interestingly, although
the pattern of Rab3 localization at the NMJ is more diffuse
in the rab3-GEFSC225 mutant and Rab3 fails to aggregate
in discrete puncta that colocalize with Brp, it still localizes
preferentially to Brp-positive areas of the NMJ (Fig.7A). In
both WT and rab3-GEFSC225 mutant NMJs average Rab3
intensity is significantly greater when measured at Brp-
positive regions compared with Brp-negative regions (Fig.
7D).
Reduced accumulation at the NMJ could result from
defective transport of Rab3 from the cell body to the distal
axon. To analyze whether axonal trafficking of Rab3 is
compromised in the rab3-GEFSC225 mutant, we examined
the localization and intensity of -Rab3 signal in periph-
eral nerves. In WT nerves, Rab3 is observed in individual
axons, often localizing in discrete clusters. However, in
the rab3-GEFSC225 mutant, Rab3 protein accumulates
throughout entire axon (Fig. 7B). The buildup of Rab3 in
peripheral axons results in a significant increase in aver-
age Rab3 intensity per nerve segment (Fig. 7E). Protein
aggregation in axons is a defining characteristic of defec-
tive axon transport in Drosophila larvae (Hurd and Saxton,
1996). Thus, the accumulation of Rab3 in peripheral
nerves indicates that Rab3-GEF is required for effective
transport of Rab3 in the fly.
We next tested whether defective Brp distribution re-
sults simply from reduced levels of Rab3 protein at the
NMJ. Even though the axonal transport of Rab3 is com-
promised in the rab3-GEFSC225 mutant, Rab3 protein still
accumulates at mutant NMJs, albeit at lower levels (Fig.
7), indicating that Rab3 is able to reach the axon terminal
in the absence of Rab3-GEF. Therefore, to increase Rab3
protein levels at the NMJ, we enhanced rab3 expression,
using the dvglutNMJX-Gal4 neuronal driver to express WT
transgenic UAS-rab3 in the rab3-GEFSC225 mutant back-
ground. Following transgenic expression of UAS-rab3,
Rab3 protein levels in the rab3-GEFSC225 mutant are sig-
nificantly increased (Fig. 8A). Average intensity of -Rab3
signal at the NMJ is equivalent between WT NMJs and
rab3-GEFSC225 mutant NMJs expressing UAS-rab3 (Fig.
8A,B). However, increased Rab3 expression does not
rescue Brp distribution in rab3-GEFSC225 mutant NMJs
(Fig. 8C). Analysis of -Brp and -DGluRIII staining in
Figure 6. Simultaneous disruption of both rab3 and rab3-GEF does not enhance the Brp distribution phenotype. A, Images of NMJs
costained with -Brp (magenta) and -DGluRIII (green) from rab3-GEFSC225 mutant, rab3rup/Df(2R)ED2076 mutant, and rab3-GEFSC225;
rab3rup/Df(2R)ED2076 double-mutant larvae. Scale bar, 2 m. B, C, Histograms show (B) the average percentage of DGluRIII clusters
apposed to Brp puncta per NMJ and (C) the average area of individual Brp puncta for the genotypes listed in A. n 
 10 NMJs for all
genotypes.
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rab3-GEFSC225 mutant larvae reveals that UAS-rab3 ex-
pression has no effect on the percentage of GluR clusters
apposed to Brp or average Brp puncta area (Fig. 8D,E).
Thus, defective AZ development in the rab3-GEFSC225
mutant is not solely due to the lack of Rab3 protein at the
NMJ.
Expression of a GTP-locked variant of Rab3 fails to
rescue rab3-GEFSC225 mutant NMJs
Because overexpression of WT Rab3 fails to rescue the
synaptic phenotype of rab3-GEFSC225 mutant NMJS,
Rab3-GEF must have additional required functions for
active zone development. Enhanced expression of WT
Rab3 may not rescue AZ development due to defective
guanine nucleotide cycling of both endogenous and
transgenically expressed Rab3. Rab3 cycles between an
active GTP-bound state and an inactive GDP-bound
state. Following the binding of GTP, Rab3 hydrolyzes the
guanine nucleotide to GDP, inactivating itself in a process
that is regulated by Rab3-GAP (GTPase accelerating pro-
tein; Cherfils and Zeghouf, 2013). GEF proteins act as
Figure 7. Rab3-GEF is required for proper trafficking of Rab3. A, Images of NMJs costained with -Brp (magenta) and -Rab3 (green)
from CS and rab3-GEFSC225/Df(1)ED7289 mutant larvae. Scale bar, 2 m. B, Images of motor nerve segments immunostained with
-Rab3 (green) and -HRP (magenta) from from CS and rab3-GEFSC225/Df(1)ED7289 mutant larvae. Scale bar, 2 m. C, Histogram
shows the average intensity of -Rab3 signal throughout the entire NMJ for the genotypes listed in A. n 
 10 NMJs for both
genotypes; p0.000001p versus CS. D, Histogram shows the average intensity of -Rab3 signal in Brp-positive and Brp-negative
regions of NMJs for the genotypes listed in A. n 
 10 NMJs for both genotypes; p0.000001q versus -Rab3 intensity at the
Brp-positive regions in WT NMJs; #p0.000001r versus -Rab3 intensity at the Brp-positive regions in rab3-GEF mutant NMJs. E,
Histogram shows the average intensity of -Rab3 signal per nerve segment as defined by -HRP staining for CS (n 
 24 nerve
segments) and rab3-GEFSC225/Df(1)ED7289 mutant larvae (n 
 12 nerve segments); p0.000001s versus CS.
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Figure 8. Transgenic expression of WT Rab3 or a GTP-locked variant of Rab3 increases Rab3 accumulation at the NMJ but fails to
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exchange factors that catalyze the release of GDP so that
a new GTP molecule can bind (Bos et al., 2007). Hence,
defective GEF activity in rab3-GEFSC225 mutant neurons
may result in a buildup of GDP-bound Rab3 and a com-
parable reduction in the GTP-bound population due to an
inability of Rab3 to release GDP following hydrolysis.
Because Rab3 must be GTP-bound to control Brp dis-
tribution across active zones (Chen et al., 2015), defective
guanine nucleotide exchange in the rab3-GEFSC225 mu-
tant may lead to the observed synaptic phenotype. There-
fore, we tested whether expression of Rab3Q80L, a GTP-
locked variant of Rab3, could rescue Brp distribution in
rab3-GEFSC225 mutant neurons. The Q80L mutation inhib-
its the GTPase activity of Rab3 even in the presence of
Rab3-GAP, resulting in a constitutively active variant
(Brondyk et al., 1993). We previously showed that expres-
sion of Rab3Q80L rescues both the morphological and
functional deficits of rab3 mutant NMJs, indicating that it
is functional in the presence of Rab3-GEF (Chen et al.,
2015). To determine whether GTP-locked Rab3 rescues
rab3-GEF mutant NMJs, we assayed Brp distribution
in rab3-GEFSC225 mutant neurons expressing UAS-
rab3Q80L. Driving UAS-rab3Q80L with DVgult-Gal4 in
rab3-GEFSC225 mutant larvae increases the accumulation
of Rab3 protein at the NMJ (Fig. 8A). Average intensity of
-Rab3 staining at the NMJ is similar betweenWT animals
and rab3-GEFSC225 mutant larvae expressing either the
UAS-rab3 or UAS-rab3Q80L variants of transgenic Rab3
(Fig. 8B). However, expression of UAS-rab3Q80L fails to
rescue the Brp-GluR apposition phenotype of the rab3-
GEFSC225 mutant (Fig. 8C). The percentage of GluR clus-
ters apposed to Brp does not increase following UAS-
rab3Q80L expression in the rab3-GEFSC225 mutant (Fig.
8D). Interestingly, driving transgenic Rab3Q80L in the
rab3-GEFSC225 mutant does modestly but significantly
decrease average Brp puncta area (p
3.07  105v). Al-
though this may correspond to a mild rescue of Brp
puncta size, previous analysis indicates that Rab3Q80L
expression also reduces average Brp puncta area when
driven in WT NMJs (Chen et al., 2015), suggesting that
Rab3Q80L may have a gain of function affect that de-
creases Brp cluster size regardless of the presence or
absence of Rab3-GEF.
It is possible that Rab3-GEF is required for Rab3Q80L
to bind GTP. While this may explain the inability of
Rab3Q80L to rescue Brp distribution in the rab3-
GEFSC225 null mutant, we would predict that Rab3Q80L
should be GTP-bound when driven in the rab3-GEFMA18
and rab3-GEFMA20 hypomorphic alleles that have unal-
tered death domains and retain partial function. However,
similar to our analysis of rab3-GEFSC225 mutant NMJs,
neuronal expression of UAS-rab3Q80L fails to rescue the
percentage of GluR clusters apposed to Brp when driven
in either the rab3-GEFMA18mutant (rab3-GEFMA18/Df: 36.1
 0.7%; UAS-rab3Q80L expressed in rab3-GEFMA18/Df:
35.7  1.4%: n 
 8 NMJs for both genotypes; p
0.814w)
or the rab3-GEFMA20 mutant (rab3-GEFMA20/Df: 40.1 
2.0%; UAS-rab3Q80L expressed in rab3-GEFMA18/Df:
38.3  1.8%; n 
 8 NMJs for both genotypes; p
0.523x).
Also similar to the rab3-GEFSC225 mutant, a moderate
decrease is observed in average Brp puncta size following
Rab3Q80L expression in the the rab3-GEFMA18 mutant
(rab3-GEFMA18/Df: 0.44  0.007 m2; UAS-rab3Q80L ex-
pressed in rab3-GEFMA18/Df: 0.32  0.010 m2; n 
 8
NMJs for both genotypes; p
1.17  107y) and in the
rab3-GEFMA20 mutant (rab3-GEFMA20/Df: 0.42  0.011
m2; UAS-rab3Q80L expressed in rab3-GEFMA18/Df: 0.34
 0.009 m2; n 
 8 NMJs for both genotypes;
p
3.96  105z). Hence, Rab3Q80L is unable to rescue
the rab3-GEF apposition phenotype even in the presence
of genetic hypomoprhs of Rab3-GEF that retain some
activity. Because Rab3-GEF levels are significantly re-
duced at rab3-GEFMA18 and rab3-GEFMA20 mutant NMJs,
it is possible that GEF activity is required locally at the
NMJ to maintain the GTP-bound state of Rab3Q80L.
However, Rab3-GEF protein is present in the cell bodies
of rab3-GEFMA18 and rab3-GEFMA20 mutant neurons at
reduced or nearly normal levels, respectively, and may
thus be available to convert Rab3Q80L to a GTP-bound
state prior to being trafficked to the NMJ.
Together, these results indicate that even though ex-
pression of Rab3Q80L increases Rab3 accumulation at
the NMJ and should enhance the population of GTP-
bound Rab3, it is unable to rescue Brp distribution in
multiple mutant alleles of rab3-GEF. Thus, our mechanis-
tic studies suggest that although Rab3-GEF may act up-
stream of Rab3 to control Rab3 trafficking and activation
in Drosophila neurons, it may also play an additional role
that is downstream of Rab3. Because the rab3 and rab3-
GEF mutant phenotypes are identical, this additional
function is likely associated with Rab3 itself. It also likely
requires the combined action of both Rab3 and Rab3-
GEF as enhancing Rab3-GEF expression in the rab3 mu-
tant fails to rescue either the percentage of GluR clusters
continued
rescue Brp distribution in the rab3-GEFSC225 mutant. A, Images of NMJs immunostained with -Rab3 (green) from WT (dvglutNMJX-
Gal4/), the rab3-GEFSC225 mutant (dvglutNMJX-Gal4, rab3-GEFSC225/Df(1)ED7289), the rab3-GEFSC225 mutant expressing UAS-rab3
(dvglutNMJX-Gal4, rab3-GEFSC225/Df(1)ED7289;; UAS-rab3/), and the rab3-GEFSC225 mutant expressing UAS-rab3Q80L
(dvglutNMJX-Gal4, rab3-GEFSC225/Df(1)ED7289;; UAS-rab3Q80L/). Scale bar, 2 m. B, Histogram shows the average intensity of
-Rab3 signal throughout the entire NMJ for the genotypes listed in A. n 
 10 NMJs for all genotypes; p
 6.7  107t versus WT,
1.35  106t versus the rab3-GEF mutant expressing UAS-rab3, and 5.12  107t versus the rab3-GEF mutant expressing UAS-
rab3Q80L. C, Images of NMJs costained with -Brp (magenta) and -DGluRIII (green) from the genotypes listed in A. Scale bar, 2 m.
D, E, Histograms show (D) the average percentage of DGluRIII clusters apposed to Brp puncta per NMJ and (E) the average area of
individual Brp puncta for the genotypes listed in A. n 
 10 NMJs for all genotypes; (D) p0.000001u versus WT; (E) p0.000001v
versus WT.
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apposed to Brp (rab3 mutant: 33.7  0.9%; UAS-rab3-
GEF expressed in rab3 mutant: 34.2  1.1%; n 
 10
NMJs for both genotypes; p
0.77393aa) or average Brp
area (rab3 mutant: 0.39  0.005 m2; UAS-rab3-GEF
expressed in rab3 mutant: 0.38  0.015 m2; n 
 10
NMJs for both genotypes; p
0.381bb). We hypothesize
that Rab3-GEF may act as an effector of Rab3 in the
process of docking Rab3-associated vesicles at release
sites to control protein composition at AZs.
Discussion
We show that Rab3-GEF controls CAZ assembly and the
distribution of AZ components across release sites at the
Drosophila NMJ. In the rab3-GEFSC225 mutant, Brp and
calcium channels fail to cluster at two-thirds of available
sites. Rather, CAZ components are concentrated at a
minority of sites where they aggregate in enlarged clus-
ters. rab3-GEFSC225 mutant NMJs function normally when
exposed to low-stimulation frequencies. However, high-
frequency stimulation reveals defective short-term facili-
tation in the rab3-GEFSC225 mutant, a hallmark of NMJs
composed primarily of sites exhibiting high-release prob-
ability characteristics. Thus, both morphological and
functional studies suggest that rab3-GEF disruption re-
sults in the formation of a small number of functional sites
with enhanced release efficacy.rab3-GEFSC225 mutant
NMJs have a synaptic phenotype that is indistinguishable
from NMJs in the rab3mutant (Graf et al., 2009), suggest-
ing that they function together to control AZ composition.
Prior studies of the mammalian and C. elegans ortho-
logues DENN/MADD/Rab3-GEP/AEX-3 indicate that Dro-
sophila Rab3-GEF likely functions as a guanine nucleotide
exchange factor for Rab3, as well as a Rab3 effector that
participates in the axonal transport of Rab3 to synapses
(Iwasaki et al., 1997; Wada et al., 1997; Oishi et al., 1998;
Coppola et al., 2002; Mahoney et al., 2006; Niwa et al.,
2008). Therefore, it is possible that Rab3 itself is dysfunc-
tional in the mutant. In support of this, we show that loss
of Rab3-GEF results in defective trafficking of Rab3 and
reduced accumulation of Rab3 at NMJs. However, mech-
anistic studies reveal that the rab3-GEF synaptic pheno-
type cannot be fully explained by loss of Rab3 function.
Attempts to rescue the rab3-GEFSC225 synaptic pheno-
type through transgenic expression of Rab3 to enhance
its accumulation at the NMJ fail to rescue Brp distribution,
potentially due to loss of GEF activity and a reduction in
GTP-bound Rab3 in the rab3-GEF mutant. However, ex-
pression of Rab3Q80L, a GTP-locked variant, also fails to
rescue the rab3-GEFSC225 mutant phenotype even though
it should enhance the GTP-bound population of Rab3 and
suppress the effects caused by loss of GEF activity. Thus,
our results support the model that in addition to its roles
in Rab3 transport and guanine nucleotide exchange,
Rab3-GEF is also required downstream of Rab3 function.
We hypothesize that Rab3-GEF acts as a Rab3 effector to
dock Rab3-associated vesicles at the synapse for proper
CAZ assembly.
Control of CAZ assembly by Rab3
Double-knockout of both rab3 and rab3-GEF fails to en-
hance the NMJ phenotype, indicating that the two pro-
teins likely act within the same molecular pathway to
control AZ development. How does Rab3 control CAZ
assembly? Prior mutational studies suggest that Dro-
sophila Rab3 acts to localize CAZ proteins via a mecha-
nism that is typical of Rab proteins. GTP-binding and
residues required for effector interaction and membrane
association are essential for proper Rab3 function at the
NMJ (Chen et al., 2015). The requirement of the Rab3
C-terminal membrane association domain suggests that
Rab3 may control Brp distribution via a standard vesicle-
docking mechanism. However, RIM is not required for
Rab3 to control Brp distribution (Graf et al., 2012). Both
the type of vesicle and the effector proteins involved in its
tethering to target membranes remain unknown.
Mammalian Rab3 is associated with neurotransmitter-
filled synaptic vesicles, Piccolo–Bassoon transport vesi-
cles (PTVs), and other types of secretory vesicles
(Darchen and Goud, 2000; Schlüter et al., 2002; Shapira
et al., 2003). The role of Rab3 in synaptic vesicle dynam-
ics has been extensively studied (Wang et al., 1997;
Schlüter et al., 2006). We have previously shown that
general alterations in synaptic vesicle release caused by
increasing or decreasing neuronal excitability do not af-
fect Brp distribution in WT or rab3 mutant NMJs (Graf
et al., 2009), so it is unlikely that Rab3 controls Brp
distribution via a synaptic vesicle associated mechanism.
Interestingly, recent studies of the synaptic vesicle protein
synaptotagmin-1 (Syt) reveal that Syt disruption also re-
sults in Brp localization defects, although the morpholog-
ical phenotype resulting from Syt knockdown is different
than that observed in rab3 and rab3-GEF mutant NMJs
(Paul et al., 2015). The fact that both Rab3 and Syt are
required for proper Brp localization suggests that a link-
age may exist between neurotransmitter release and CAZ
assembly; however, the mechanism of this potential link-
age is unclear. A simpler explanation for Rab3 function in
the control of CAZ assembly involves the docking of
transport vesicles homologous to mammalian PTVs,
which contain a pre-assembled complex of AZ proteins
for insertion at nascent release sites during synapse de-
velopment (Zhai et al., 2001). Such a model is consistent
with previous studies that suggest that Drosophila Rab3
acts to nucleate the formation of new Brp clusters at AZs
(Graf et al., 2009). However, an analogous population of
transport vesicles has not been identified in Drosophila
neurons, and further work will be required to determine
whether such vesicles are involved in this mechanism of
Rab3 action to control Brp distribution.
Analysis of Rab3-GEF function for controlling AZ
composition
We now show that Rab3-GEF is an essential player in this
Rab3-associated mechanism to control CAZ assembly.
Previous work in other organisms indicates that Rab3-
GEF acts upstream of Rab3 to regulate Rab3 function.
Consistent with studies in mammals and C. elegans (Iwa-
saki et al., 1997; Niwa et al., 2008), we show that Dro-
sophila Rab3-GEF is required for the axonal trafficking of
Rab3. Rab3 protein accumulates in axon shafts, leading
to decreased levels at rab3-GEFSC225 mutant NMJs. Dis-
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rupted localization of Rab3 and its associated vesicles
may lead to defective Brp distribution in the rab3-
GEFSC225 mutant. However, enhanced expression of both
transgenic WT Rab3 and Rab3Q80L fail to rescue the
rab3-GEFSC225 mutant phenotype even though the accu-
mulation of Rab3 is increased at NMJs to endogenous
levels. These results suggest that disrupted Brp distribu-
tion in the rab3-GEFSC225 mutant is not solely due to
defective Rab3 trafficking. Conversely, although en-
hanced expression of Rab3 may increase the overall ac-
cumulation of Rab3 at the terminal, Rab3-GEF may also
be required for more discrete localization of Rab3 within
the NMJ, which may not be rescued by Rab3 overexpres-
sion. The localization pattern of Rab3 within the NMJ in
rab3-GEFSC225 mutants expressing transgenic Rab3 dif-
fers from endogenous Rab3; however, this may also be
due to the fact that CAZ protein distribution is defective at
these NMJs.
A second potential mechanism of Rab3-GEF action is
via its role as a GEF. The mammalian and C. elegans
orthologues of Drosophila Rab3-GEF act as GEFs to cat-
alyze GDP to GTP exchange (Wada et al., 1997; Mahoney
et al., 2006). It has previously been shown that GTP-
binding is required for Rab3 to control Brp distribution as
GTP-binding defective variants of Rab3 fail to rescue the
rab3 mutant phenotype (Chen et al., 2015). Thus, rab3-
GEF knockout may disrupt Rab3 function in Drosophila
neurons by reducing the GTP-bound population of Rab3.
However, our studies indicate that the rab3-GEF synaptic
phenotype cannot solely be due to loss of GEF activity or
defective Rab3 localization. Enhancing the population of
GTP-bound Rab3 by expression of Rab3Q80L, a hydro-
lysis defective variant, fails to rescue the rab3-GEFSC225
mutant phenotype. Rab3Q80L accumulates at the NMJ at
levels similar to endogenous Rab3. Furthermore, previous
analysis indicates that Rab3Q80L can rescue the morpho-
logical and physiological phenotypes of the rab3 mutant,
indicating that it is functional when Rab3-GEF is present.
Hence, the lack of rescue following Rab3Q80L expression
in the rab3-GEF mutant suggests that the synaptic phe-
notype is not simply due to loss of GEF activity. Additional
lines of evidence support this finding. GEF activity has
been mapped to the death domain in the mammalian and
C. elegans orthologues of Rab3-GEF. However, rab3-
GEFMA18 and rab3-GEFMA20 mutants both have synaptic
phenotypes nearly as severe as the rab3-GEFSC225 mu-
tant, even though the death domain is intact in the MA18
and MA20 mutant alleles. Furthermore, studies in mice
reveal the presence of significant amounts of GTP-bound
Rab3 despite DENN/MADD disruption (Yamaguchi et al.,
2002; Niwa et al., 2008), potentially due to the presence of
other proteins that can act as GEFs for Rab3.
It is possible that Rab3Q80L itself requires the nucleo-
tide exchange activity of Rab3-GEF to transition into a
GTP-bound state, which could explain the lack of rescue
when Rab3Q80L is expressed in the rab3-GEFSC225 mu-
tant. However, Rab3Q80L also fails to rescue the synaptic
phenotype when driven in the rab3-GEFMA18 and rab3-
GEFMA20 hypomorphs that retain some activity. This may
be due to a general decrease in Rab3-GEF protein
throughout rab3-GEFMA18 mutant neurons. However,
Rab3-GEF protein is present at nearly normal levels in the
cell bodies of rab3-GEFMA20 mutant neurons even though
it is absent at rab3-GEFMA20 mutant NMJs. Although it is
possible that Rab3Q80L requires GEF activity in the NMJ
to maintain its active state, the presence of Rab3-GEF in
rab3-GEFMA20 cell bodies suggests that activation of
Rab3Q80L in the rab3-GEFMA20 mutant could occur prior
to trafficking to the NMJ. In mammalian neurons, axonal
transport of Rab3 is most effective when Rab3 is in a
GTP-bound state (Niwa et al., 2008), suggesting that GEF
activity generally occurs in the cell body, as well as at the
synapse. Thus, together, our results suggest that Rab3-
GEF plays other roles in the control of AZ development in
addition to its functions in Rab3 trafficking and as a GEF.
How might Rab3-GEF act in addition to its previously
identified roles? Because the rab3-GEF and rab3 mutant
phenotypes are indistinguishable from each other and
from the double-mutant, this additional function must be
within the Rab3 pathway. We hypothesize that Rab3-GEF
also acts downstream of Rab3 to control AZ composition.
Rab3-GEF is a Rab3 effector protein, linking Rab3 to
kinesin for axonal trafficking (Niwa et al., 2008). Rab3-GEF
may also act as a Rab3 effector at the NMJ itself, playing
a direct role in the docking of Rab3-associated vesicles at
the plasma membrane. Conversely, Rab3-GEF may be
required for an unidentified postdocking step as has been
suggested by studies of synaptic vesicle exocytosis in
mouse neurons lacking Rab3-GEP (Yamaguchi et al.,
2002). Additional work will be required to determine the
mechanism by which Rab3 and Rab3-GEF act to control
CAZ protein composition at active zones.
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